Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Schmitt-Grohé, F. Schreiner, L. van den Boom, D. N‘Gampolo, O. Eickmeier, R. Schubert, I. Broeckart, S. Zielen, M. Lentze (Bonn, Frankfurt, Germany). TGFβ1 genotype in correlation to TGFβ1 induced sputum (IS) and serum in cystic fibrosis (CF). Eur Respir J 2011; 38: Suppl. 55, 4552

Member's Comments

No comment yet.

Related content which might interest you: Relationship between nasal potential difference (NPD) and respiratory function in cystic fibrosis (CF) patients Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001 Elevated apoptosis rate of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonitis (NSIP) – strong positive correlation with bronchoalvoelar lavage (BAL) neutrophil count. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Diagnostic value of induced sputum (IS) in interstitial lung disease (ILD) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007 Nasal potential difference (NPD) in cystic fibrosis (CF) and non-CF patients with borderline sweat test Source: Eur Respir J 2001; 18: Suppl. 33, 215s Year: 2001 8.1 ancestral haplotype (AH) protects against colonization in cystic fibrosis (CF) Source: Eur Respir J 2005; 26: Suppl. 49, 726s Year: 2005 Repeat polymorphisms (pol.) in the NOS-1 gene and its association with the clinical severity of cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 Correlation of induced sputum (IS) particles size distribution (PDS) and pulmonary function test (PFT) in asthmatics patients (A-pts) Source: Eur Respir J 2004; 24: Suppl. 48, 604s Year: 2004 Monitoring small airways disease (SAD) in cystic fibrosis (CF) Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011 Diagnostic value of CD4/CD8 ratio in induced sputum (IS) in interstitial lung disease (ILD) Source: Annual Congress 2004 - Pathobiological and clinical investigations in interstitial lung diseases Year: 2004 Pseudomonas aeruginosa (Pa) antibiotic resistance (AR): Comparison in adults and children with cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Intestinal current measurement (ICM) as a new diagnostic test for cystic fibrosis (CF) Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation Year: 2011 Azithromycin (AZM) regulates glutathione-S-transferases (GST)s in cystic fibrosis (CF) airway cells Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Early stage asymptomatic (HRCT detectable) patients with IPF showed augmented serum surfactant protein D (SP-D) Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002 Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease Source: Eur Respir J 2007; 30: Suppl. 51, 121s Year: 2007 Safety of sputum induction (SI) in interstitial lung disease (ILD) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007 LATE-BREAKING ABSTRACT: Connexin 37 and Connexin 43 genotypes in correlation to cytokines in induced sputum and blood in cystic fibrosis (CF) Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research Year: 2012 Dual release ciprofloxacin for inhalation (DRCFI) reduces sputum pseudomonas aeruginosa (Pa) density and delays time to infective pulmonary exacerbation in non-cystic fibrosis (CF) bronchiectasis (BE) Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011 Improved survival at low lung function in cystic fibrosis (CF) Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009 Variability of the lung clearance index (LCI) assessed pre and post physiotherapy in patients with cystic fibrosis (CF) Source: Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology Year: 2008